RRDD REOPENING BORDERS

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19

Healthcare management and consulting services in connection with infectious disease and COVID-19; developing worksite specific epidemic risk scoring profiles; analyzing employer and site-based preparedness; consulting on communication strategies and developing trainings regarding employer and employee preparedness; identifying and preparing for onsite safety and health measures, preparing screening and monitoring protocols to address exposure to infectious disease and COVID-19; developing intervention protocols to address exposure of infectious disease and COVID-19; developing site-specific resource planning, delivering human resources and management communications and training, employee communications and training, site-specific reporting and monitoring regarding employer, employee, customer and passenger health status

Provision of non-downloadable software to track, manage, and analyze data related to employee, customer and passenger health status; platform as a services (PaaS) featuring a system for rapidly reviewing and analyzing Covid test results, and communicating those results

Healthcare, wellness and medical services; provision of clinical assessments, evaluations and diagnostic lab testing; providing healthcare, wellness information and public health information in connection with infectious disease and COVID-19; Medical testing for diagnostic or treatment purposes, namely, on-site testing for diagnosis and treatment of COVID-19, including both testing and analysis of test results